Download pdf
Analysis of the effects of psychotropic drugs targeting neurotransmitters and their receptors
- 1 School of Chemistry and Materials, Fujian Normal University, Fujian, China
- 2 School of Life Sciences, Zhuhai College of Science and Technology, Zhuhai, Guangdong, China
* Author to whom correspondence should be addressed.
Abstract
Neurotransmitters play a crucial role in the production and treatment of psychiatric disorders. A neurotransmitter is a chemical that transmits signals and is very closely associated with a variety of neural activities such as mood, memory, growth and development, and drug addiction. In recent years, significant progress has been made in the research on psychiatric diseases caused by uneven neurotransmitter secretion and drug treatment for psychiatric disorders. By studying the way drugs act on different neurotransmitters and their receptors, regulate the functional activities of the brain or body, so as to effectively improve the symptoms of patients, and analyze the mechanism of action of each drug to obtain the most effective drugs with minimal side effects to further treat psychiatric diseases. However, the current scientific and technological conditions are limited, and the specific mechanism of action of some drugs has not yet been determined. This article analyzes various neurotransmitters, such as serotonin (5-HT), norepinephrine, dopamine, psychiatric diseases caused by unbalanced secretion, and the mechanism of action of their representative therapeutic drugs, which provides a theoretical basis for the clinical treatment of psychiatric diseases in the future. There are still a small number of drugs with unclear mechanisms of action and unsolved drug side effects, and future research can focus on the direction of drug application safety.
Keywords
Neurotransmitters, psychiatric disorders, serotonin (5-HT), norepinephrine dopamine, antipsychotics, depression.
[1]. Hyman S E 2005 Neurotransmitters Current Biology 15 5 R154-R158
[2]. Yohn C N Gergues M M & Samuels B A 2017 The role of 5-HT receptors in depression Molecular Brain 10 1-12
[3]. Shahcheraghi S H Ayatollahi J Lotfi M Aljabali A A Al-Zoubi M S Panda P K & Tambuwala M M 2023 Gene therapy for neuropsychiatric disorders: Potential targets and tools CNS & Neurological Disorders-Drug Targets Formerly Current Drug Targets-CNS & Neurological Disorders 22 1 51-65
[4]. Poznić-Ješić M Ješić A Babović-Filipović J & Živanović O 2012 Extrapyramidal syndromes caused by antipsychotics Medicinski Pregled 65 11-12 521-526
[5]. Leathwood P D 1987 Tryptophan availability and serotonin synthesis Proceedings of the Nutrition Society 46 1 143-156
[6]. Gjerris A Stub A & Rafaelsen O J 1987 5-HT and 5-HIAA in cerebrospinal fluid in depression Journal of Affective Disorders 12 1 13-22
[7]. Hyttel J 1994 Pharmacological characterization of selective serotonin reuptake inhibitors SSRIs International Clinical Psychopharmacology 9 19-26
[8]. Zhang Z D 2018 Comparative clinical efficacy and safety analysis of fluoxetine hydrochloride and venlafaxine in the treatment of postpartum depression Modern Diagnosis and Treatment 29 22 66-67 78
[9]. Liu H & Liu W J 2014 Observation on the efficacy of venlafaxine in the treatment of Parkinson's disease combined with depression Inner Mongolia Journal of Traditional Chinese Medicine 8 96
[10]. FDA Label Risperdal tablet Risperdal solution
[11]. Schatzberg A & Nemeroff C 2009 The American Psychiatric Publishing Textbook of Pharmacology 4th ed Washington DC: American Psychiatric Publishing Inc
[12]. Bhatt S Devadoss T Manjula S N et al 2021 5-HT3 receptor antagonism: A potential therapeutic approach for the treatment of depression and other disorders Current Neuropharmacology 19 9 1545-1559
[13]. Belujon P & Grace A A 2017 Dopamine system dysregulation in major depressive disorders International Journal of Neuropsychopharmacology 20 12 1036-1046
[14]. Hetrick S E McKenzie V E Bailey A P et al 2021 New generation antidepressants for depression in children and adolescents: A network meta-analysis Cochrane Database of Systematic Reviews 5 5 CD013674
[15]. Hu G H Wu X H & Ye X L 2024 Relationship between levels of central neurotransmitters DA 5-HT NE and the efficacy in patients with first-episode depressive disorder Medical Theory and Practice 37 12 2097-2099
Cite this article
He,Y.;Zheng,S. (2024). Analysis of the effects of psychotropic drugs targeting neurotransmitters and their receptors. Theoretical and Natural Science,62,64-71.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).